TY - JOUR
T1 - Immunosuppression by lymphocytic choriomeningitis virus infection
T2 - competent effector T and B cells but impaired antigen presentation
AU - Althage, Alana
AU - Odermatt, Bernhard
AU - Moskophidis, Demetrius
AU - Kündig, Thomas
AU - Hengartner, Urs Hoffman‐Rohrer Hans
AU - Zinkernagel, Rolf M.
PY - 1992/7
Y1 - 1992/7
N2 - Lymphocytic choriomeningitis virus (LCMV) may cause a severe immunosuppression in mice. Its pathogenesis is apparently dependent on LCMV‐specific CD8 effector T cells that mediate the destruction of virus‐infected cells which are normally essentially involved in immune responses. Evaluation of various LCMV isolates in this study established a general correlation between their tropism for lymphohemopoietic cells and immunosuppression. When immune responses were assessed as the capacity of mice to mount an anti‐vaccinia virus cytotoxic T cell response or an IgG response to vesicular stomatitis virus (VSV), after a primary LCMV infection, LCMV‐Armstrong, WE, Clone 13 and Docile were increasingly immunosuppressive in a dose‐dependent fashion with respect to both extent and duration. Analysis of lymphocyte subpopulations showed variable effects of the various LCMV isolates that did not reveal patterns readily explaining immunosuppression. To evaluate whether LCMV infection affected T and/or B cell functions directly or whether antigen presentation was impaired, adoptive transfer experiments were performed. Untreated or irradiated but uninfected normal recipient mice receiving adoptively transferred T or B cells from LCMV‐WE or Docile‐infected immunosuppressed donor mice responded within 30%–100% of normal ranges in both assay systems. In contrast, when T or B cells from normal donors were transferred to irradiated or non‐irradiated LCMV‐immunosuppressed recipients, they failed to mount a significant cytotoxic T cell response against vaccinia virus or an IgG response to VSV. Thus, the T and B cells from LCMV‐immunosuppressed mice were able to function within normal ranges; in contrast, histologically and functionally, antigen presentation was severely impaired in LCMV‐immunosuppressed mice.
AB - Lymphocytic choriomeningitis virus (LCMV) may cause a severe immunosuppression in mice. Its pathogenesis is apparently dependent on LCMV‐specific CD8 effector T cells that mediate the destruction of virus‐infected cells which are normally essentially involved in immune responses. Evaluation of various LCMV isolates in this study established a general correlation between their tropism for lymphohemopoietic cells and immunosuppression. When immune responses were assessed as the capacity of mice to mount an anti‐vaccinia virus cytotoxic T cell response or an IgG response to vesicular stomatitis virus (VSV), after a primary LCMV infection, LCMV‐Armstrong, WE, Clone 13 and Docile were increasingly immunosuppressive in a dose‐dependent fashion with respect to both extent and duration. Analysis of lymphocyte subpopulations showed variable effects of the various LCMV isolates that did not reveal patterns readily explaining immunosuppression. To evaluate whether LCMV infection affected T and/or B cell functions directly or whether antigen presentation was impaired, adoptive transfer experiments were performed. Untreated or irradiated but uninfected normal recipient mice receiving adoptively transferred T or B cells from LCMV‐WE or Docile‐infected immunosuppressed donor mice responded within 30%–100% of normal ranges in both assay systems. In contrast, when T or B cells from normal donors were transferred to irradiated or non‐irradiated LCMV‐immunosuppressed recipients, they failed to mount a significant cytotoxic T cell response against vaccinia virus or an IgG response to VSV. Thus, the T and B cells from LCMV‐immunosuppressed mice were able to function within normal ranges; in contrast, histologically and functionally, antigen presentation was severely impaired in LCMV‐immunosuppressed mice.
UR - http://www.scopus.com/inward/record.url?scp=0026720985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026720985&partnerID=8YFLogxK
U2 - 10.1002/eji.1830220720
DO - 10.1002/eji.1830220720
M3 - Article
C2 - 1623925
AN - SCOPUS:0026720985
SN - 0014-2980
VL - 22
SP - 1803
EP - 1812
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 7
ER -